A pharmacokinetic, pharmacodynamic and pharmacogenetic study of sorafenib (BAY-43-9006 Tosylate) and blood pressure elevation in patients with advanced malignancies

Trial Profile

A pharmacokinetic, pharmacodynamic and pharmacogenetic study of sorafenib (BAY-43-9006 Tosylate) and blood pressure elevation in patients with advanced malignancies

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 03 Feb 2006

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Cancer
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 03 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top